UPenn Says St. Jude Cancer Therapy Patent Is Invalid
The University of Pennsylvania on Friday sought to declare invalid a patent held by St. Jude Children's Hospital related to a "groundbreaking" new immunotherapy treatment for cancer that is at the...To view the full article, register now.
Already a subscriber? Click here to view full article